MHD6 dietary methylamines Flashcards
At any time, how many distinct microbiota-associated metabolites (MAMs) are in the circulation of healthy individuals
upwards of 200
Where do MAMs come from?
produced by gut bacteria from dietary substrates, intestinal secretions and xenobiotics
How do MAMs enter the blood?
many are taken up from the upper gastrointestinal tract into the bloodstream via the hepatic portal vein
What happens between the gut and MAMs?
shuttling information between host cells and the gut microbiota. The gut-liver axis
Does phenylacetic acid undergo first pass metabolism?
No
what does phenylacetic acid contribute to?
the progression of non-alcoholic fatty liver disease in obesity
Where in the liver are MAMs and drugs detoxified?
the smooth endoplasmic reticulum of liver cells (hepatocytes)
What is first pass metabolism?
Metabolism in the liver or gut before it reaches the systemic circulation
Where does 75% of the liver’s blood supply come from?
The hepatic portal vein, the direct venous outflow from the intestine
Why are there differences in the composition and function of the gut microbiota of patients who are obese/have NAFLD and healthy individuals?
reduced integrity of the gut barrier - becomes leaky
what happens if an individual has a leaky gut?
The MAMs healthy/unhealthy individuals are exposed to will differ, because of the changes in microbiota function.
Give an example of the microbial byproducts diseased individuals will be exposed to
lipopolysaccharide from gram negative bacteria & antigens
What does the gut-liver axis refer to?
interplay between the gut and liver in health and disease, with the gut microbiota central to this relationship
What does the gut-liver axis directly contribute to?
host–microbiota co-metabolism
What happens in host–microbiota co-metabolism
chemical communication between specific hepatic cellular pathways and specific MAMs
What is uptake of microbiota-associated metabolites (MAMs) into hepatic circulation is influenced by?
health status
What does a leaky gut mean?
malfunctioning tight-junctions
What does NAFLD stand for?
Non-alcoholic fatty liver disease - gut microbiotia contributes to it
What does steatosis mean?
It’s a condition where the liver accumulates lipid, with or without inflammation
NAFLD is the most common cause of ______________
chronic liver disease
What is metabolic syndrome?
Having at least three of the five following medical conditions: Abdominal obesity High blood pressure High blood sugar High serum triglycerides Low high-density lipoprotein levels
What is metabolic syndrome associated with a higher risk of?
Cardiovascular disease and type 2 diabetes.
How are you able to tell if someone has NAFLD?
Only histological assessment of the degree of steatosis in liver biopsy samples allows accurate diagnosis of NAFLD
What’s the problem with diagnosing NAFLD?
obtaining biopsy samples is an expensive, invasive approach not without risk, it is not practical for screening large numbers of patients routinely.
Where can disruption of the gut–liver axis in steatosis be found?
the gut microbiome, hepatic transcriptome (gene expression profile) and metabolome
What is the gut microbiome of patients with NAFLD characterised by?
- low microbial gene richness (i.e. it has a lower number of unique microbial genes)
- small increases in levels of Gram-negative Proteobacteria
- Signalling pathways associated with gram-negative bacteria in the liver are activated
Where is PAA found higher in?
Patients with NAFLD
What has PAA shown to contribute to?
accumulation of lipids in liver tissue, in cell-line and mice models
How would identification of a specific MAM that contributes directly to disease offer?
The potential to develop a low-cost, rapid, blood test for the accurate diagnosis of NAFLD
Apart from increased PAA what do patients with steatosis show?
- decrease of hepatic expression of insulin receptor (INSR)
- decrease of short/branched chain acyl-CoA dehydrogenase (ACADSB)
- Hepatic lipoprotein lipase (LPL) expression – directly associated with hepatic lipid (triglyceride; TG) accumulation is increased
- p-Akt (& the normal response to insulin) are decreased
What is steatosis positively associated to?
- high circulating levels & urinary levels of the MAMs branched-chain amino acids (BCAAs)
- aromatic amino acids (AAA)
- high serum phenylacetic acid (PAA)
- high hepatic LPL
What does decreased phosphorylated Akt (p-Akt) and the normal response to insulin, directly contribute to, in NAFLD patients and is associated with metabolic syndrome?
insulin resistance
What is first pass metabolism?
Sometimes referred to as pre-systematic metabolism - the metabolism of a drug or microbiota-associated metabolite before it reaches the systemic circulation, and it can happen in the gut or the liver
From what 3 sources are microbiota-associated metabolites derived?
- dietary substrates
- intestinal secretions
- xenobiotics
What is the gut-liver axis?
The interplay between the gut and the liver in health and disease, with the gut microbiota central to this relationship because of its production of metabolites that can directly influence or be modified by the liver
Why is the liver potentially affected by or involved with metabolism of microbiota-associated metabolites?
The liver is constantly exposed to a range of microbiota-associated metabolites because 75% of its blood supply comes from the hepatic portal vein, the direct venous outflow from the intestine.
What is host-microbiota co-metabolism?
Host-metabolism is the communication between host-associated cellular pathway and microbiota-associated metabolites. In the context of the gut-liver axis, this communication is between specific hepatic cellular pathways and specific microbiota-associated metabolites. These metabolites can be subject to first-pass metabolism in some instances, but modified or unmodified microbiota-associated metabolites can influence host-microbiota co-metabolism